Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice

le McMahon, Gregory C., Brown, Gordon A.
Foilsithe in Rev Urol (2017)

Utilization of individualized prostate cancer and genomic biomarkers for the practicing urologist

le McMahon, Gregory C., Brown, Gordon A., Mueller, Thomas J.
Foilsithe in Rev Urol (2017)

Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Gr...

le McGinley, Kathleen F, McMahon, Gregory C, Brown, Gordon A
Foilsithe in Rev Urol (2015)

PROSTATIC URETHRAL BIOPSY HAS LIMITED UTILITY IN COUNSELING PATIENTS REGARDING FINAL URETHRAL MARGIN STATUS DURING ORTHOTOPIC NEOBLADDER RECONSTRUCTION

le Kassouf, Wassim, Spiess, Philippe E., Brown, Gordon A., Liu, Ping, Grossman, H. Barton, Dinney, Colin P. N., Kamat, Ashish M.
Foilsithe in J Urol (2008)

Barriers to accessing urethroplasty

le Consolo, Michael J., Syed, Kirin K., Robison, Christopher, McFadden, Jacob, Shalowitz, David I., Brown, Gordon A., Sussman, David O., Figler, Bradley D.
Foilsithe in Rev Urol (2016)

P0 Stage at Radical Cystectomy for Bladder Cancer is Associated with Improved Outcome Independent of Traditional Clinical Risk Factors

le Kassouf, Wassim, Spiess, Philippe E., Brown, Gordon A., Munsell, Mark F., Grossman, H. Barton, Siefker-Radtke, Arlene, Dinney, Colin P.N., Kamat, Ashish M.
Foilsithe 2007

ABILITY OF CLINICAL GRADE TO PREDICT FINAL PATHOLOGIC STAGE IN UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA: IMPLICATIONS FOR THERAPY

le BROWN, GORDON A., MATIN, SURENA F., BUSBY, J. ERIK, DINNEY, COLIN P. N., GROSSMAN, H. BARTON, PETTAWAY, CURTIS A., MUNSELL, MARK F., KAMAT, ASHISH M.
Foilsithe 2007

The Role of Radical Cystectomy in Patients with Clinical T4b Bladder Cancer

le Black, Peter C., Dinney, Colin P.N., Brown, Gordon A., Kassouf, Wassim, Siefker-Radtke, Arlene O., Munsell, Mark F., Grossman, H. Barton, Kamat, Ashish M.
Foilsithe 2010

Is Vascular Endothelial Growth Factor Modulation a Predictor of the Therapeutic Efficacy of Gefitinib for Bladder Cancer?

le Kassouf, Wassim, Brown, Gordon A., Black, Peter C., Fisher, Mark B., Inamoto, Teruo, Luongo, Tony, Gallagher, David, Bar-Eli, Menashe, McConkey, David J., Adam, Liana, Dinney, Colin P. N.
Foilsithe in J Urol (2008)

DISTINCTIVE EXPRESSION PATTERN OF ErbB FAMILY RECEPTORS SIGNIFY AN AGGRESSIVE VARIANT OF BLADDER CANCER

le Kassouf, Wassim, Black, Peter C., Tuziak, Tomasz, Bondaruk, Jolanta, Lee, Sangkyou, Brown, Gordon A., Adam, Liana, Wei, Caimiao, Baggerly, Keith, Bar-Eli, Menashe, McConkey, David, Czerniak, Bogdan, Dinney, Colin P.
Foilsithe 2007

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines

le Shore, Neal D., Antonarakis, Emmanuel S., Cookson, Michael S., Crawford, E. David, Morgans, Alicia K., Albala, David M., Hafron, Jason, Harris, Richard G., Saltzstein, Daniel, Brown, Gordon A., Henderson, Jonathan, Lowentritt, Benjamin, Spier, Jeffrey M., Concepcion, Raoul
Foilsithe in Prostate (2020)